Vyome (HIND) vs Tvardi Therapeutics (TVRD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vyome (HIND) has outperformed Tvardi Therapeutics (TVRD) over the past year, losing 67.1% versus a loss of 97.3%. Over five years, TVRD leads with a -99.8% price change compared with -100.0% for HIND. Tvardi Therapeutics is the larger company by market cap ($14.7 million vs $14.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HIND | TVRD |
|---|---|---|
| Share price | $2.04 | $1.10 |
| Market cap | $14.32M | $14.67M |
| 1-day change | -0.97% | +1.85% |
| YTD return | -40.70% | -74.42% |
| 1-year return | -67.15% | -97.27% |
| 5-year return | -100.00% | -99.77% |
| P/E ratio (TTM) | 1.15 | — |
| EPS (TTM) | $1.78 | $-2.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.56 | $43.65 |
| 52-week low | $1.75 | $0.93 |
| Distance from 52-week high | -68.90% | -97.48% |
| Average volume | 13.60K | 538.92K |
| Shares outstanding | 7.02M | 13.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HIND has outperformed TVRD by 30.1 percentage points over the past year.
HIND vs TVRD FAQ
Which is bigger, Vyome or Tvardi Therapeutics?
Tvardi Therapeutics (TVRD) is larger, with a market capitalization of $14.67M compared with $14.32M for Vyome (HIND).
Which stock has performed better over the past year, HIND or TVRD?
HIND returned -67.15% over the past 12 months, compared with -97.27% for TVRD (price return, excluding dividends). Past performance does not predict future results.
Are Vyome and Tvardi Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.